Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 12,580.70 +125.86 1.01%
S&P 500 1,332.42 +14.60 1.11%
Nasdaq 2,870.99 +33.46 1.18%
Ticker Volume Price Price Delta
STOXX 50 2,160.31 +12.39 0.58%
FTSE 100 5,391.14 +34.80 0.65%
DAX 6,396.84 +73.65 1.16%
Ticker Volume Price Price Delta
Nikkei 8,585.88 -71.20 -0.82%
TOPIX 720.15 -6.88 -0.95%
Hang Seng 18,897.10 -158.34 -0.83%
Gold 1,553.70 +0.17%
EUR-USD 1.2468 -0.2747%
Nasdaq 2,870.99 +1.18%
DJIA 12,580.70 +1.01%
S&P 500 1,332.42 +1.11%
FTSE 100 5,391.14 +0.65%
STOXX 50 2,160.31 +0.58%
DAX 6,396.84 +1.16%
Oil (WTI) 90.41 -0.39%
U.S. 10-year 1.724% -0.014
BAC:US 7.44 +4.06%
FB:US 28.84 -9.62%
  • Exchange: -
  • Sector: Consumer, Non-cyclical
  • Industry: Biotechnology
  • Sub-Industry: Medical-Biomedical/Gene

Medimmune LLC

MEDI:US

Acquired

Medimmune LLC (MEDI:US) was acquired by AZN:LN


Company Profile

MedImmune LLC operates as a biopharmaceutical company. The Company offers biological products, therapeutic and preventive medicines, synagis, and flumist. MedImmune serves its customers globally.

Advertisement